Dsc Advisors, L.P. Merck & Co., Inc. Transaction History

Dsc Advisors, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $117,158 - $131,614	-1,386 Reduced 31.58%	3,003 $259,000
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $14,276 - $16,183	-171 Reduced 3.75%	4,389 $400,000
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $335,205 - $375,744	4,560 New	4,560 $374,000
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $148,832 - $206,289	-2,349 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $182,235 - $205,631	2,349 New	2,349 $214,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Dsc Advisors, L.P., based on Form 13F filings with the SEC.

Stay updated on Dsc Advisors, L.P. with notifications on news.